A Novel Colon-Specific Osmotic Pump Capsule of Panax notoginseng Saponins (PNS): Formulation, Optimization, and In Vitro-In Vivo Evaluation

AAPS PharmSciTech
Dong JinSong Gao

Abstract

In the current study, a novel colon-specific osmotic pump capsule of Panax notoginseng saponins was developed to achieve colon-specific release, a zero-order, thus to promote the efficacy of Panax notoginseng saponins. The capsule was assembled using a semi-permeable capsule shell with contents including Panax notoginseng saponins, sodium chloride (NaCl), and Ludipress. The semipermeable membrane was made of cellulose acetate (CA), along with polyethylene glycol (PEG) 6000 for flexibility and strength, and Eudragit® S100 for colon-specific targeting. The in vitro dissolution test showed an approximately zero-order release of Panax notoginseng saponins over 12 h at pH 7.8 through the pores on the membrane. Meanwhile, the drug release from the optimal formulation was found to be independent of equipment type or agitation speed. Rather, it depended on mainly the osmotic pressure of the dissolution media. The in vivo test in beagle dogs demonstrated that the relative bioavailability of the current system was 487.42% in comparison to that of the marketed product, yet with a prolonged retention time. The novel controlled delivery system for Panax notoginseng saponins in the current study utilizing colon-specific and osmotic pump syst...Continue Reading

References

Oct 31, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·V Pillay, R Fassihi
May 22, 2008·Expert Opinion on Drug Delivery·Sanjay K Jain, Anekant Jain
Jan 25, 2011·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Anil ChaudharyRanjit Singh
Feb 15, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kenneth C WatermanVidya Swaminathan
May 19, 2011·The Journal of Pharmacy and Pharmacology·Juan F Marquez RuizJohn F Gilmer
Jun 16, 2011·Current Topics in Medicinal Chemistry·Suneela S Dhaneshwar, Gaurav Vadnerkar
Dec 27, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Alexandra HillKarsten Mäder
Mar 26, 2013·Expert Opinion on Drug Delivery·Mayur Mahendrakumar Patel
Sep 16, 2014·International Journal of Pharmaceutics·Dandan LiuWeisan Pan
Nov 8, 2014·AAPS PharmSciTech·Arti BanerjeeSubhash Gore
May 24, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Long Binh VongYukio Nagasaki
Jun 6, 2016·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Bhavik Bhatt, Vijay Kumar
Jun 10, 2016·Drug Development and Industrial Pharmacy·Hao PanTianbao Chen
Dec 6, 2016·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Bhavik Bhatt, Vijay Kumar
Jan 27, 2017·Circulation·Emelia J BenjaminUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Apr 6, 2017·Journal of Zhejiang University. Science. B·Huan-Huan PangJian-Mei Huang
Jun 22, 2017·Phytotherapy Research : PTR·Haiying SongChenglong Wang

❮ Previous
Next ❯

Citations

Aug 6, 2019·Science Robotics·Joseph C NortonPietro Valdastri
May 30, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yi HeCui Yang
May 18, 2021·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Wen FuHuixia Lv

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay

Software Mentioned

DAS
AUTO

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.